RecruitingNCT05572073

Otoferlin Gene-mediated Hearing Loss Natural History Study

A Natural History Study in Individuals With Otoferlin Gene-mediated Hearing Loss

Sponsor

Akouos, Inc.

Enrollment

150 participants

Start Date

Jul 14, 2022

Study Type

OBSERVATIONAL

Conditions

This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.

Max Age: 44 Years

Clinical presentation of bilateral sensorineural hearing loss (SNHL), including auditory neuropathy (AN) / auditory neuropathy spectrum disorder (ANSD) phenotype or medical history of AN / ANSD phenotype earlier in life
Mutation(s) in the otoferlin gene
Able and willing to comply with all study requirements, as evidenced by successful completion of the informed consent (and assent, if applicable) process
Additional Criteria for Inclusion in the Prospective Phase:
Presence of OAE / CM and absent / abnormal ABRs in at least one ear (that does not have a cochlear implant) within 12 months prior to or at the Month 0 visit

Unwillingness or inability of the potential participant and/or legally authorized representative to comply with all protocol requirements
Presence of cochlear nerve deficiency and/or cochlear nerve dysplasia
Additional Criteria for Exclusion from the Prospective Phase:
Presence of bilateral cochlear implants at the time of record review or planned within the next 6 months
Presence of middle ear or auditory brainstem implant(s) at the time of record review or planned within the next 6 months
Any condition that would not allow the potential participant to complete follow-up assessments during the course of the study and/or, in the opinion of the Investigator, makes the potential participant unsuitable for the study
Note: Potential participants will not be excluded based on their sex, gender, race, or ethnicity

Interested in this trial?

Get notified about updates and connect with the research team.